Mediastinal lymphadenopathy means that lymph nodes in the center of your chest are swollen beyond their normal size. The mediastinum is the space between your lungs that holds your heart, major blood vessels, windpipe, and esophagus, and it contains dozens of lymph nodes organized into distinct groups. On a CT scan, a lymph node with a short-axis diameter over 10 mm is generally considered enlarged. This finding shows up on chest imaging for a wide range of reasons, from common infections to serious conditions like cancer, so the term itself is a description of what’s happening rather than a diagnosis.
Why Lymph Nodes Enlarge in the Chest
Lymph nodes swell when they’re actively filtering something abnormal, whether that’s an infection, inflammatory process, or cancer cells. The causes of mediastinal lymphadenopathy fall into three broad categories.
Infections: Tuberculosis, fungal infections like histoplasmosis and coccidioidomycosis, aspergillosis, and even ordinary pneumonia can all trigger lymph node enlargement in the mediastinum. These infections cause the nodes to fill with immune cells as the body fights off the organism.
Inflammatory and autoimmune conditions: Sarcoidosis is one of the most recognizable causes. It produces a distinctive pattern of symmetric, bilateral swelling in the lymph nodes at both lung roots (the hilar nodes), often alongside enlargement of nodes near the trachea. That symmetric pattern is an important clue because it’s unusual in lymphoma, tuberculosis, or metastatic cancer, which tend to be more one-sided or irregular. Other inflammatory conditions, including granulomatosis with polyangiitis, can also cause mediastinal node enlargement.
Cancer: Lymphoma (both Hodgkin and non-Hodgkin types) frequently involves mediastinal nodes. Lung cancer is the other major concern, since cancer cells from the lung drain directly into these nodes. Metastases from cancers elsewhere in the body can also settle here. In lung cancer staging, the location of involved lymph nodes directly determines the stage of the disease. Nodes on the same side as the tumor are classified differently from those on the opposite side, and involvement of mediastinal nodes (called N2 or N3 disease) significantly changes treatment options.
Symptoms You Might Notice
Mildly enlarged lymph nodes often cause no symptoms at all and are discovered incidentally on a CT scan ordered for something else. When nodes grow large enough to press on surrounding structures, though, the symptoms depend on what’s being compressed.
Pressure on the windpipe or airways causes cough, shortness of breath, or a sensation of difficulty breathing, especially during exertion. If enlarged nodes compress the superior vena cava, the large vein that returns blood from the upper body to the heart, you can develop facial swelling, neck vein distension, and a feeling of fullness in the head. This is called superior vena cava syndrome and is considered a medical emergency. In severe cases, large masses of nodes can compress the pulmonary artery or even the heart itself, leading to chest pain, palpitations, fainting, or dangerous fluid buildup around the heart (pericardial effusion). These compression symptoms are more common with aggressive lymphomas that grow rapidly in the anterior mediastinum.
How It’s Found and Measured
A standard chest CT scan is the most common way mediastinal lymphadenopathy is detected. Radiologists measure each node along its short axis, the narrower dimension, because this measurement stays consistent regardless of the node’s orientation. Nodes under 10 mm in short-axis diameter are considered normal. Those between 10 and 15 mm are flagged as enlarged, and nodes 15 mm or larger are considered clearly abnormal and more likely to need further evaluation.
CT imaging alone can tell you a node is enlarged, but it cannot reliably tell you why. Inflammatory conditions like tuberculosis and sarcoidosis can make nodes light up intensely on PET-CT scans, mimicking cancer (a false positive). Conversely, some lower-grade cancers, like carcinoid tumors or certain types of lung adenocarcinoma, may not show much metabolic activity and can be missed (a false negative). This is why imaging findings often need to be confirmed with a tissue sample.
How a Diagnosis Is Confirmed
When imaging raises enough concern, the next step is typically a biopsy to examine the cells inside the enlarged node. Two main approaches are used.
Endobronchial ultrasound-guided needle aspiration (EBUS) has become the preferred first-line procedure. A thin, flexible scope is passed through the mouth into the airways, and an ultrasound probe on its tip guides a small needle through the airway wall into the lymph node. It’s done as an outpatient procedure under light sedation, with a complication rate of about 1.2%. Studies comparing EBUS head-to-head with the older surgical approach found it performs just as well. In one large study of 153 patients, both methods had identical diagnostic accuracy of 93%, and in a per-node analysis, EBUS actually outperformed surgical biopsy at certain node locations.
Mediastinoscopy, the surgical alternative, involves a small incision at the base of the neck and insertion of a scope into the mediastinum under general anesthesia. It’s more invasive, with a complication rate up to 2.5% that includes rare but serious risks like injury to major blood vessels or vocal cord nerves. It’s still used when EBUS results are inconclusive or when certain node stations can’t be reached with a scope through the airways.
What Happens After It’s Found
Not every enlarged mediastinal lymph node requires a biopsy. Current guidelines from the American College of Radiology recommend no further workup for asymptomatic nodes smaller than 15 mm when there’s no other concerning finding. For nodes 15 mm or larger without a clear explanation, the recommended path is a PET-CT scan, a clinical consultation, or a follow-up chest CT in three to six months. If the node grows on follow-up imaging, biopsy is recommended. If it stays the same size or shrinks, no further workup is needed.
In a survey of pulmonologists and other specialists, most said they would refer for biopsy once nodes reached 11 to 15 mm, particularly if there were additional risk factors like a smoking history, weight loss, or an abnormal PET scan. The decision to biopsy versus monitor depends heavily on context: a 12 mm node in a 30-year-old with recent pneumonia is treated very differently from a 12 mm node in a 65-year-old smoker with a lung mass.
Patterns That Point to Specific Causes
Radiologists look at more than just size. The distribution and appearance of enlarged nodes can narrow the list of possibilities considerably.
Sarcoidosis has one of the most distinctive patterns: symmetric enlargement of nodes at both lung roots, often with right paratracheal node involvement. This bilateral, mirror-image appearance is unusual enough that it strongly suggests sarcoidosis over lymphoma or metastatic disease, which tend to involve nodes asymmetrically. Mediastinal lymphadenopathy without any hilar involvement is rare in sarcoidosis.
Lung cancer metastases typically follow the lymphatic drainage from the tumor, so nodes closest to the tumor enlarge first, progressing to more distant stations. A node containing calcification can suggest prior granulomatous infection like tuberculosis or histoplasmosis, while clusters of matted nodes that seem to merge together can point to either tuberculosis or lymphoma. Necrosis (dark, low-density areas within a node) is more common in infections and aggressive cancers. None of these imaging features are definitive on their own, but they help clinicians decide how urgently to pursue a tissue diagnosis.